Navigation Links
Beardsworth Continues to Strengthen Oncology Operations
Date:5/4/2011

FLEMINGTON, N.J., May 4, 2011 /PRNewswire/ -- Beardsworth announces the promotion of Evette Riegel, RN, to Senior Director, Clinical Operations and Project Management and the addition of Saishree Ramalingam, MS, MPhil as Senior Project Manager.  

(Photo:  http://photos.prnewswire.com/prnh/20110504/NY95605 )

In her new role, Ms. Riegel will lead Beardsworth's expanded focus in oncology clinical operations and execution of all clinical programs.

"Evette's expertise and insight provide an added dimension that strengthens our client services and capabilities across our global OncologyOne(SM) and therapeutic vaccine initiatives.  Her global trial experience and extensive therapeutic knowledge combined with her personal insight as a critical care nurse, give her a unique perspective from which to lead our patient-centric, project management teams," said Michael O'Brien, President & CEO.

Ms. Riegel joined Beardsworth in 2006 as a Senior Project Manager and became Director, Clinical Operations in 2008 with a leading role in the integration of Beardsworth's global services and oncology operations. Previously, Ms. Riegel worked at Quintiles as a global project manager as well as Discovery Laboratories, ViroPharma, and Wyeth.

Saishree Ramalingam, MS, MPhil joins Beardsworth as a Senior Project Manager responsible for leading the company's oncology trials. An experienced research clinician, Ms. Ramalingam has over 13 years experience across multiple therapeutic areas and global projects with a special focus in oncology and vaccines.

Prior to Beardsworth, Ms. Ramalingam held project manager positions at Celgene, Pfizer, GSK/Reliant, Merck, as well as PharmaNet, Applied Clinical Intelligence, and PRA International. She received her master of science at the University of Akron and a master of philosophy from Avinashilingam Deemed Uni
'/>"/>

SOURCE Beardsworth
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Alison Martin, MD and Robert W. Malone, MD Join Beardsworth
2. InstaCare Corp. Continues Turnaround & Reports 291% Revenues Increase in 2Q 2008
3. China-Biotics, Inc. Continues to Broaden Bulk Additives Client Base
4. Cequent Pharmaceuticals Meets Novartis Option Fund Milestone; Continues to Next Phase to Validate Inflammatory Bowel Disease Targets in Vivo
5. Use of Biologic Agents Continues to Expand Among US Rheumatologists - Can New Agents Shift the Treatment Paradigm in Rheumatoid Arthritis?
6. Investment and Growth in US Medical Technology Industry Continues Despite Challenging Public Markets
7. FDA Continues Review of Takedas New Drug Application for Alogliptin (SYR-322), a DPP-4 Agent for Type 2 Diabetes
8. Custom NX(R) Drug Eluting Stent System Continues to Demonstrate Favorable Outcomes in Challenging Patient Populations at One, Two and Three Years
9. ATS Forcefield Anti-platelet Technology Continues to Demonstrate Positive Results
10. ACORN CRO Continues Growth in Strong Third Quarter
11. Frontage Laboratories Continues to Grow Its China Business and Add Corporate Financial, Regulatory and Clinical Pharmacology Talent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2014)... (PRWEB) July 12, 2014 ... various reagents used in the life science ... the life science reagents market towards remarkable ... manufacturers and providers of life science reagents. ... Report: http://www.transparencymarketresearch.com/life-sciences-reagents-analytical-reagents.html . , The global ...
(Date:7/11/2014)... 11, 2014 , Not for release, ... or from any jurisdiction where to do so would constitute ... Shire plc ("Shire" or the "Company") (LSE: SHP, NASDAQ: ...  Shire confirms it has held a meeting with representatives of ... without the prior agreement or approval of AbbVie. ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 BCC Research ... DIGITAL POLYMERASE CHAIN REACTION (PCR) TECHNOLOGY: GLOBAL MARKETS ... (PCR) technology reached nearly $140 billion in 2013. This ... registering a five-year compound annual growth rate (CAGR) of ... number of interesting and exciting possibilities within the broader ...
(Date:7/11/2014)... 2014 /CNW/ - Sunovion Pharmaceuticals Canada Inc. (Sunovion) today ... acetate) for use as a once-daily adjunctive therapy for ... who are not satisfactorily controlled with conventional therapy.  APTIOM ... under 18 years of age. Epilepsy ... according to Epilepsy Canada, it affects 0.6% of the ...
Breaking Biology Technology:Transparency Market Research: Life Science Reagents Market- PCR Reagent Kits, Cell and Tissue Culture, Flow Cytometry, Electrophoresis and Chromatography 2Transparency Market Research: Life Science Reagents Market- PCR Reagent Kits, Cell and Tissue Culture, Flow Cytometry, Electrophoresis and Chromatography 3Shire plc - Statement re: Media Speculation 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 2Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 3Sunovion Pharmaceuticals Canada Inc. Announces Health Canada Approval of APTIOM(TM) (eslicarbazepine acetate) as a Once-Daily Adjunctive Treatment for Partial-Onset Seizures in Patients with Epilepsy 4
... World-class investigators affiliated with US Oncology Research ... and displayed Dec. 6-10 at the Henry B. Gonzales ... Cancer Symposium ( SABCS ), an international scientific symposium ... in breast cancer. (Logo: http://photos.prnewswire.com/prnh/20110912/DA65711LOGO ) ...
... Calif., Dec. 1, 2011  AtheroNova Inc. (OTCBB: AHRO) ... and development of compounds to regress atherosclerotic plaque, ... ("CardioNova"), a Russian subsidiary of Maxwell Biotech Group ... for AtheroNova,s AHRO-001 lead compound has been ratified ...
... 2011 The collaboration of two leading cell image ... facility for archiving, sharing, and analyzing microscope images in ... and the National Center for Microscopy and Imaging Research ... have joined forces to provide a unified interface. This ...
Cached Biology Technology:US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium 2US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium 3US Oncology Research Affiliated Physician to Present Findings From Innovative Clinical Trial at 2011 CTRC-AACR San Antonio Breast Cancer Symposium 4AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug 2AtheroNova and Maxwell Biotech Group Ratify Agreement to Develop New Atherosclerosis Drug 3Two Top Biological Imaging Centers Offer Powerful Free Online Tool to Researchers, Educators, and Public 2Two Top Biological Imaging Centers Offer Powerful Free Online Tool to Researchers, Educators, and Public 3
(Date:7/11/2014)... two different ways that allow unprecedented experimental insights ... of oxygen molecules in photosynthesis. The two studies ... Nature Communications . , "The new knowledge will ... oxidation, which are key components for building artificial ... energy in fuels like hydrogen, ethanol or methanol," ...
(Date:7/11/2014)... marginal division of the striatum is also involved ... degree of substance P in the striatal marginal ... and his team, College of Biophotonics, South China ... substance P receptor, neurokinin 1 was highly expressed ... normal rats. Unilateral or bilateral injection of an ...
(Date:7/11/2014)... Using spider toxins to study the proteins that let ... say they have stumbled upon a biological tactic that ... insect plagues in a safe and environmentally responsible way. ... be lethal for one species and harmless for a ... target specific pests without harming beneficial species like bees. ...
Breaking Biology News(10 mins):Molecular snapshots of oxygen formation in photosynthesis 2Potent spider toxin 'electrocutes' German, not American, cockroaches 2Potent spider toxin 'electrocutes' German, not American, cockroaches 3
... understanding of the process cells use to ensure that ... of each chromosome ?a process that must be exquisitely ... retardation. The new work reveals how gluelike protein complexes ... meiosis ?the specialized cell division process that produces sperm ...
... first birthday, according to new infant mortality statistics for ... (NCHS). , The infant mortality rates showed no significant ... first time since 1958. , In 2003, the ... live births, which was statistically unchanged from the 2002 ...
... Nerve signals relayed directly to the pancreas after eating ... sugar control, according to a report in the June ... sensitivity to such signals might offer a new approach ... which the pancreas cells that produce insulin, or beta ...
Cached Biology News:What controls stickiness of 'smart' chromosomal glue 2What controls stickiness of 'smart' chromosomal glue 3What controls stickiness of 'smart' chromosomal glue 4US infant mortality rate fails to improve 2Increased sensitivity to nerve signals keeps diabetes at bay 2
... The Experion HighSens analysis kit for 25 ... to perform high-sensitivity RNA analysis (at picogram ... This kit includes 25 RNA HighSens microfluidic ... 2 x 20 microliters RNA HighSens stain, ...
Monoclonal Anti-Cystatin A tissue culture supernatant Solution containing 15 mM sodium azide human cystatin A ...
... SSCP kit provides all the accessories necessary ... single-stranded conformation polymorphism analysis (SSCP) with the ... includes a cooling finger adaptor for use ... sets of 20 cm plates, 2 sets ...
... Experion StdSens analysis kit for 25 chips ... perform standard-sensitivity RNA analysis (at nanogram levels) ... kit includes 25 RNA StdSens microfluidic chips, ... x 20 microliters RNA StdSens stain, 2 ...
Biology Products: